ABSTRACT Objective: To conduct a systematic review and meta-analysis assessing the cardiorespiratory fitness (CRF) among individuals with and without type 2 diabetes Materials and methods: The current review was registered in PROSPERO under the number CRD42018082718. MEDLINE, EMBASE, and Cochrane Library databases were searched from inception through February 2022. Eligibility criteria consisted of observational or interventional studies that evaluated CRF through cardiopulmonary exercise testing or six-minute walk test in individuals with type 2 diabetes compared with individuals without type 2 diabetes. For data extraction, we used baseline CRF assessments of randomized clinical trials or follow-up CRF assessments in observational studies. We performed a meta-analysis using maximal oxygen consumption (VO2max), and distance walked in the 6MWT as primary outcomes. They were extracted and expressed as mean differences (MDs) and 95% CIs between treatment and comparator groups. The meta-analysis was conducted using Review Manager (RevMan) software. Results: Out of 8,347 studies retrieved, 77 were included. Compared with individuals without type 2 diabetes, individuals with diabetes achieved a lower VO2max (−5.84 mL.kg−1.min−1, 95% CI −6.93, −4.76 mL.kg−1.min−1, p = <0.0001; I2 = 91%, p for heterogeneity < 0.0001), and a smaller distance walked in 6MWT (−93.30 meters, 95% CI −141.2, −45.4 meters, p > 0.0001; I2: 94%, p for heterogeneity < 0.0001). Conclusion: Type 2 diabetes was associated with lower cardiorespiratory fitness, as observed by lower VO2max on maximal tests, and smaller distance walked in 6MWT, however the quality of studies was low.

Resumo Fundamento: Crianças e adolescentes com cardiopatia congênita frequentemente apresentam alterações na sua capacidade de exercício que pode ser avaliada através de vários testes funcionais. Objetivo: Avaliar a capacidade funcional de crianças e adolescentes com cardiopatias congênitas (CC) através de revisão sistemática e metanálise. Métodos: A revisão incluiu estudos observacionais, dados da primeira avaliação de ensaios clínicos randomizados ou acompanhamento após ensaios clínicos que avaliaram a capacidade funcional através teste de exercício cardiopulmonar, teste ergométrico, teste de caminhada de seis minutos ou teste do degrau em crianças e adolescentes. Foram incluídos indivíduos com CC, idade entre seis e 18 anos e seus controles saudáveis. A avaliação quantitativa foi realizada por metanálise, comparando o consumo máximo de oxigênio (VO2max) entre crianças e adolescentes com CC e seus pares saudáveis. Resultados: Vinte e cinco dos 2.683 estudos identificados na pesquisa atenderam aos critérios de inclusão. A medida do VO2máx mostrou que os pacientes com CC apresentaram uma diminuição de 9,31 ml/Kg/min (IC 95%: -12,48 a -6,13; I2, 94,3%, P para heterogeneidade < 0,001) em comparação ao grupo controle. A metanálise dos dados de frequência cardíaca máxima (FCM) alcançada durante o teste de exercício cardiopulmonar e teste ergométrico, avaliado por 18 estudos, mostrou um valor de -15,14 bpm (IC 95%: -20,97 a -9,31; I2; 94,3%, P para heterogeneidade < 0,001) em comparação ao grupo controle. Conclusão: Crianças e adolescentes com CC apresentam menor VO2máx e FCM em relação a controles saudáveis.

Abstract Background: Children and adolescents with congenital heart disease often have alterations in their exercise capacity that can be evaluated by various functional testing. Objective: To evaluate the functional capacity of children and adolescents with congenital heart disease (CHD) with systematic review and meta-analyses. Methods: The review included observational studies, data from the first evaluation of randomized clinical trials or observational follow-up periods after clinical trials which evaluated functional capacity by cardiopulmonary exercise test, stress testing, six-minute walk test or step test, in children and adolescents with CHD, aged between six and 18 years, and comparisons with healthy controls in the same age group. The quantitative assessment was performed by meta-analysis, by comparing the maximal oxygen consumption (VO2max) of children and adolescents with CHD and respective control groups. Results: Twenty-five of 2.683 studies identified in the search met the inclusion criteria. The VO2max measurement showed that patients with CHD have a decrease of 9.31 ml/Kg/min (95% CI. -12.48 to -6.13; I2, 94.3%, P for heterogeneity < 0.001) compared with the control group. The meta-analysis of the data of maximum heart rate (HR) reached during cardiopulmonary test and stress testing, retrieved from 18 studies, showed a HR value of -15.14 bpm (95% CI. -20.97 to -9.31; I2, 94.3%, P for heterogeneity < 0.001) compared with the control group. Conclusion: Children and adolescents with CHD have lower VO2max and HR compared to controls.